Document Detail

Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
MedLine Citation:
PMID:  20833609     Owner:  NLM     Status:  In-Process    
OBJECTIVE: To review the available literature on the effects of angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), and calcium channel blockers (CCBs) or combinations of these agents on stroke outcomes in hypertensive patients.
DATA SOURCES: A Medline search was conducted using the search terms stroke and antihypertensives, calcium channel blockers, angiotensin-converting enzyme inhibitors, or angiotensin II receptor blockers from 1985 to August 17, 2009.
STUDY SELECTION: Randomized controlled clinical trials with at least 400 randomized patients were selected if at least one of the treatment arms used a CCB, ACEI, or ARB to evaluate stroke outcomes in hypertensive patients.
DATA SYNTHESIS: The prevalence of stroke is high in the United States, accounting for approximately 150,000 deaths per year. Early identification and treatment of hypertension to quickly achieve blood pressure reduction is critical in the prevention of stroke. Many trials have provided evidence that CCBs, ACEIs, and ARBs are effective in stroke prevention. Most patients require two or more antihypertensive drugs to achieve blood pressure goals. Because of their complementary actions, combination antihypertensive therapy with a renin-angiotensin-aldosterone system (RAAS) blocker and a CCB may help reduce stroke incidence to a greater extent than either of the monotherapies.
CONCLUSION: A growing body of clinical trial data suggest that aggressive combination antihypertensive therapy, including a RAAS blocker and CCB, may help reduce stroke incidence. Fixed-dose combination therapy is an important consideration in optimizing blood pressure control and patient adherence to therapy in stroke prevention.
Robert L Talbert
Related Documents :
10507629 - Reliability and precision of a new thoracic electrical bioimpedance monitor in a lower ...
12771599 - Endogenous glycosides in critically ill patients.
12688399 - Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance ...
2028489 - Twenty-four-hour variation of blood pressure in vascular dementia of the binswanger type.
17971649 - General care in stroke: relevance of glycemia and blood pressure levels.
7493419 - Aortic distensibility in patients with cerebrovascular disease.
24804369 - Hypertension prevalence and knowledge assessment in rural haiti.
16160899 - Left ventricular end-systolic stress/diameter relation as a contractility index and as ...
970619 - A simple device designed to protect operating theatres against atmospheric pollution by...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Pharmacists Association : JAPhA     Volume:  50     ISSN:  1544-3450     ISO Abbreviation:  J Am Pharm Assoc (2003)     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-09-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101176252     Medline TA:  J Am Pharm Assoc (2003)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e116-25     Citation Subset:  IM    
College of Pharmacy, University of Texas at Austin, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal wo...
Next Document:  Tobacco users' perceptions of a brief tobacco cessation intervention in community pharmacies.